» Articles » PMID: 16476720

Soluble Adhesion Molecules in End-stage Renal Disease: a Predictor of Outcome

Overview
Date 2006 Feb 16
PMID 16476720
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Inflammation is thought to contribute to initiation and aggravation of atherosclerosis through a process predominantly mediated by adhesion molecules. The aims of this study were to investigate the association between the concentrations of circulating soluble intercellular (sICAM-1) and vascular cellular (sVCAM-1) adhesion molecules and clinical outcome, and to evaluate the effect of antihypertensive drugs on sICAM-1 and sVCAM-1 concentrations in end-stage renal disease (ESRD) patients.

Methods: We prospectively investigated 310 (191 males) incident ESRD patients, 53+/-12 years old, shortly before the start of renal replacement therapy. Glomerular filtration rate (GFR) was 6.4 (range 0.8-16.5) ml/min/1.73 m(2). Plasma sICAM-1 and sVCAM-1 were measured by enzyme-linked immunosorbent assay (ELISA) kits. Survival was determined from the day of examination, with a mean follow-up period of 39 (range 1-123) months.

Results: In non-adjusted analysis, high sICAM-1 and sVCAM-1 levels were associated with all-cause and cardiovascular (P<0.001) mortality. After adjusting for age, gender, diabetes mellitus, serum cholesterol, C-reactive protein (CRP), subjective global assessment and angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB), the association between high sICAM-1 and mortality remained significant for all-cause (HR 1.9; CI 1.2-2.9, P = 0.004) and cardiovascular (HR 1.8; CI 1.1-3.1, P = 0.02) mortality, and a high sVCAM-1 was associated with all-cause mortality (HR 1.7; CI 1.04-2.7, P = 0.03). Furthermore, the concentration of sICAM-1, but not sVCAM-1, was lower in patients receiving ACEI/ARB (254+/-83 vs 275+/-92 ng/ml; P<0.05) or patients receiving calcium channel blockers (CCB, 251+/-75 vs 273+/-95 ng/ml; P<0.05) than in non-users.

Conclusions: In ESRD patients, sICAM-1 and sVCAM-1 are independent predictors of all cause and cardiovascular death. The use of ACEI/ARB or CCB was associated with decreased concentrations of soluble adhesion molecules.

Citing Articles

Protein Biomarkers and Major Cardiovascular Events in Older People With Advanced CKD: The European Quality (EQUAL) Study.

Hayward S, Chesnaye N, Hole B, Aylward R, Meuleman Y, Torino C Kidney Med. 2024; 6(1):100745.

PMID: 38162538 PMC: 10757029. DOI: 10.1016/j.xkme.2023.100745.


AST-120 Improves Cardiac Dysfunction in Acute Kidney Injury Mice via Suppression of Apoptosis and Proinflammatory NF-κB/ICAM-1 Signaling.

Shen W, Chou Y, Shi L, Chen Z, Tu H, Lin X J Inflamm Res. 2021; 14:505-518.

PMID: 33658826 PMC: 7917393. DOI: 10.2147/JIR.S283378.


Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation.

Wojtaszek E, Oldakowska-Jedynak U, Kwiatkowska M, Glogowski T, Malyszko J Oxid Med Cell Longev. 2021; 2021:6651367.

PMID: 33628373 PMC: 7895596. DOI: 10.1155/2021/6651367.


Endothelial Damage, Inflammation and Immunity in Chronic Kidney Disease.

Diaz-Ricart M, Torramade-Moix S, Pascual G, Palomo M, Moreno-Castano A, Martinez-Sanchez J Toxins (Basel). 2020; 12(6).

PMID: 32492843 PMC: 7354562. DOI: 10.3390/toxins12060361.


Selected cardiovascular risk factors in early stages of chronic kidney disease.

Jagiela J, Bartnicki P, Rysz J Int Urol Nephrol. 2020; 52(2):303-314.

PMID: 31955363 DOI: 10.1007/s11255-019-02349-1.